Neuros Medical said it named Tom Wilder, the CEO who led Sequent Medical to a $280 million acquisition by Terumo Corp. (TYO:4543), to take the corner office. “Neuros Medical, with its patented Altius system high-frequency nerve block technology, has the opportunity to develop important therapy options for patients who experience significant pain as a result […]
7 medtech stories we missed this week: Aug. 25, 2017
From InspireMD’s Swiss distribution deal to CoreLink’s stackable guide wire launch, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD announces Swiss distribution deal InspireMD announced in an Aug. 25 press release that it has signed an agreement with 1a Medical to distribute the CGuard EPS […]
7 medtech stories we missed this week: May 26, 2017
From Merck’s new licensing agreement to surgical study data being touted, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. […]
VCs put more into medtech last year | Medtech funding for the week of January 19, 2015
Press Release: EarlySense chair sensor receives FDA clearance
EarlySense touts FDA win for novel chair-based vital sign sensor
Monitoring systems maker EarlySense this week touted FDA clearance for its 1st-of-a-kind Chair Sensor Solution, a continuous vital sign monitor based in a chair.
The contact-free system monitors heart rate, respiratory rate and movement in patients seated upright, a position that EarlySense says improves healing, reduces the risk of complications and shortens length of stay for patients in the hospital.
Welch Allyn debuts monitor with tech from Masimo, Covidien, EarlySense
Nihon Kohden grabs Defibtech | Wall Street Beat
CardioInsight names Patrick Wethington new CEO | Personnel Moves
EarlySense lands FDA clearance for its updated monitoring systems
Massachusetts-based medical device maker EarlySense received FDA clearance for its oximetry-integrated bedside system and central display system to help the clinicians provide a higher level of supervision for post-surgical patients.
MassDevice Network
@MassDevice
LinkedIn
Google+